Medical Update: Hormone Receptor-Positive Metastatic Breast Cancer

Hormone receptor-positive metastatic breast cancers test positive for estrogen (ER-positive) or progesterone (PR-positive) receptors , or both, and often respond to anti-estrogen therapies.

During this session at Living Beyond Breast Cancer's 2019 Conference on Metastatic Breast Cancer, Neil Vasan, MD, PhD at Memorial Sloan Kettering Cancer Center details approved and pipeline hormonal therapies, targeted therapies and chemotherapy regimens that are used in metastatic disease, as well as ways to manage common side effects.

To view more resources from our conference, visit lbbc.org/2019metsconf/resources